Drug Discontinuation
HPS Pharmacies wish to give notice that GlaxoSmithKline Consumer Healthcare Australia have discontinued Calsource® Ca1000 effervescent tablets as follows:
Calsource® Ca1000 Effervescent Tablets
Calcium carbonate + calcium lactate gluconate 1.75g/2.263g
ARTG 146629
While there is currently no direct substitute, the following table contains some products that may be considered for indirect substitution in individual cases.
| Product | Active Ingredients | Elemental Calcium | Form |
| Caltrate® | Calcium carbonate 1500mg | 600mg | Tablet |
| Cal-600 | Calcium carbonate 1500mg | 600mg | Tablet |
| Cal-500 | Calcium carbonate 1250mg | 500mg | Chewable tablet |
| Cal-Sup™ | Calcium carbonate 1250mg | 500mg | Chewable tablet |
| VÖOST™ Calcium + D3 | Calcium carbonate 1249mg + Colecalciferol (vitamin D3) 200 IU | 500mg | Effervescent tablet |
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact GlaxoSmithKline Consumer Healthcare on 1800 028 533 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates